Company to showcase efficacy of its precision Oral Appliance Therapy devices in treating Obstructive Sleep ApneaSAN FRANCISCO, April 20, 2022 (GLOBE…
Elusys becomes wholly-owned biodefense subsidiary of NightHawk Plans to expand ANTHIM® distribution abroad DURHAM, N.C., April 20, 2022 (GLOBE NEWSWIRE)…
Groundbreaking partnership includes debut of Lowell Farms-branded lighters within the Zippo portfolioSALINAS, Calif., April 20, 2022 (GLOBE NEWSWIRE) -- In a…
New services include pathogen identification, microbiome profiling and rapid turnaround sequencing of clinical isolatesROCKVILLE, Md., April 20, 2022 (GLOBE NEWSWIRE)…
*** David Reardon, Luigi Naldini, Brad Loncar ***MILAN, Italy and NEW YORK, April 20, 2022 (GLOBE NEWSWIRE) -- Genenta Science…
Clinical benefit again observed for OTO-413 versus placebo for multiple efficacy endpoints based on responder analysis at both Days 57…
Please read the full announcement in the attached PDF Attachment 2022_12_Reduction_of_share_capital
--94% cumulative protective effect against COVID-19 in previously-infected individuals that subsequently received Clover’s COVID-19 vaccine candidate-- --First and only COVID-19…
- 356 IPF Patients Enrolled - - Topline Data Anticipated Mid-2023 - SAN FRANCISCO, April 20, 2022 (GLOBE NEWSWIRE) --…
LOS ANGELES, April 20, 2022 (GLOBE NEWSWIRE) -- Enochian BioSciences (NASDAQ: ENOB). Enochian BioSciences Inc., a company focused on gene-modified…